{"id":207838,"date":"2018-04-19T10:35:02","date_gmt":"2018-04-19T10:35:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=207838"},"modified":"2018-04-19T10:35:02","modified_gmt":"2018-04-19T10:35:02","slug":"buergers-disease-market-highlights-by-diagnosis-and-treatment-latest-developments-healthy-growth-of-31-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/buergers-disease-market-highlights-by-diagnosis-and-treatment-latest-developments-healthy-growth-of-31-by-2023_207838.html","title":{"rendered":"Buerger\u2019s Disease Market Highlights by Diagnosis and Treatment | Latest Developments | Healthy Growth of 3.1% by 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Buerger\u2019s Disease Market”<\/div>\n<\/div>\n<\/div>\n
Buerger\u2019s Disease Market information, by diagnosis (blood tests, The Allen’s test, angiogram, and others), by treatment (Smoking Cessation, Other Treatments, and others), by end user- global forecast till 2023<\/div>\n

The Global <\/span><\/span>Buerger’s Disease Market<\/span><\/span><\/a> is growing steadily and is expected to continue its growth during the forecast period. Global Buerger’s disease market is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 383.0 million by 2023.<\/span><\/span><\/p>\n

Key Market Players:<\/span><\/span><\/strong><\/p>\n

There are various players operating in the global alopecia drugs market, some of the major players are FUJIFILM Holdings Corporation (Japan), General Electric Company (US), Koninklijke Philips N.V. (the Netherlands), pluristem (Israel), Shimadzu Corporation (Japan), Siemens Healthcare GmbH (Germany), STEMPEUTICS RESEARCH PVT LTD (India) Toshiba Medical Corporation (Japan), t2cure GmbH (Germany), and others. <\/span><\/span><\/p>\n

Market Overview:<\/span><\/span><\/strong><\/p>\n

Buerger’s disease is also known as thromboangiitis obliterans (TAO). Buerger’s disease is a rare and severe disease of veins and arteries especially in arms and legs. In this disease, blockage of blood vessels of hands and feet occurs in this disease condition. Blood clots or thrombi obstruct the blood vessels, resultantly, the blood vessels become inflamed and swell which reduces the blood flow. <\/span><\/span><\/p>\n

Get a Sample Copy of This Report @ <\/span><\/span><\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/1638<\/span><\/span><\/em><\/a> .<\/span><\/span><\/em><\/p>\n

This leads to the destruction or damage of skin tissues that may cause gangrene and other infections. The exact causes of this disease are unknown but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud’s phenomenon etc. There is no 100% cure for this disease.<\/span><\/span><\/p>\n

Considering the market scenario of global Buerger’s disease, some important factors are driving the growth for this market one of them is increasing investment in research, development of new therapies and clinical trials. Approvals for new treatments or therapies plays vital role in the growth of this market. <\/span><\/span><\/p>\n

In 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger’s Disease. Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger’s disease. Introduction and adoption of advanced diagnostic medical devices are another key drivers for the market growth.<\/span><\/span><\/p>\n

Intended Audience:<\/span><\/span><\/strong><\/p>\n